Skip to main content

Indications of Interest

We test a new way to measure interest in upcoming IPOs.
  • Author:
  • Publish date:

I love to experiment, and always have. So, when our ever-inventive technologist came up with a new way of measuring just what people did when they came to the ipoPros Web site, I started wondering what ipoPros readers might teach us about the IPO market.

One thing that occurred to me was that I could measure the number of times that a given deal was looked at on a given day or for, say, a week. Which got me wondering if there was any relationship between the number of hits a deal got on the ipoPros system and the actual performance of the IPO or secondary offering.

So, after a week of carefully collecting the data, I began the process of sifting through log files. Almost immediately, it was clear that a very small number of deals garnered a disproportionate percentage of users' eyeballs. By running a simple query, I was able to determine the total number of hits received by each of the 349 deals in the ipoPros system from 12:01 a.m. Monday to midnight Sunday -- a full week of traffic.

To make this as meaningful as possible, I narrowed down the request to just those deals scheduled to price this week. Here, listed in order of popularity (i.e., hits received) are the five most popular deals scheduled to price this week:

    Time Warner Telecom: 1,245 hits Alloy Online: 1,061 hits Copper Mountain Networks: 870 hits Tenfold: 587 hits Scient: 618 hits

Scroll to Continue

TheStreet Recommends

Now, what conclusion can we draw from this exercise? Are the users of the ipoPros site more adept at picking deals than I am? Will some sophisticated Web counter replace me? That's the exciting part: We won't know until our little experiment has run its course. So, check back next week for the initial results.

In the meantime, here are the deals for this week:

Ben Holmes is the founder of, a Boulder, Colo.-based research boutique specializing in the analysis of equity syndicate offerings. This column is not meant as investment advice; it is instead meant to provide insight into the methods of new and secondary offerings. Neither Holmes nor his firm has entered indications of interest in any of the companies discussed in this column. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Holmes appreciates your feedback at